Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib for Post-Surgical Dental Pain
NCT00026819Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rofecoxib in postoperative pain (3 arms), sponsored by National Institute of Dental and Craniofacial Research. Primary endpoints: Pain Intensity Visual Analog Scale at 48 hours and Pain Intensity Category Scale at 48 hours. Started Nov 2001; status: completed.
02
Drugs
rofecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00026819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026819.